Midjourney Medical goes from generating ‘cat images’ to full-body ultrasound scans

The buried detail here is regulatory exposure: medical imaging devices in the US require FDA 510(k) clearance or De Novo authorization, and Midjourney has no visible track record navigating that process, which typically runs 12 to 36 months even for established medtech players.

This is largely disconnected from recent activity in the space we have covered. It belongs instead to a quieter but accelerating pattern of generative AI companies deciding their core model capabilities are table stakes and that durable margins require owning the hardware layer or the data pipeline that feeds it. Midjourney's move into ultrasound hardware is an extreme version of that logic: rather than licensing to a medtech partner, they appear to be building the device itself. That vertical integration bet is expensive and slow, and it shifts the competitive risk from model quality to clinical validation and reimbursement, two areas where consumer AI credibility offers almost no advantage.

Watch whether Midjourney files a 510(k) or De Novo submission with the FDA within the next 18 months. No filing by end of 2027 would suggest the Scanner remains a research or demonstration project rather than a commercial medical product.